UBS fines for misselling structured products could be first of many

UBS criticised for its practices relating to sales of structured products

“We first started to get involved in these cases almost immediately after Lehman went bust and during that time we have had a steady flow of people who were told a variety of false things about structured products,” says Seth Lipner, partner at Deutsch and Lipner in New York. The Swiss bank has lost five cases to date, he says.

The products UBS sold were mostly the 100% principal-protected notes and return optimisation securities with some capital protection, a large number of which were issued

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here:

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...


You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: